» Articles » PMID: 32481565

Stigmasterol Causes Ovarian Cancer Cell Apoptosis by Inducing Endoplasmic Reticulum and Mitochondrial Dysfunction

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2020 Jun 3
PMID 32481565
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Phytosterols have physiological effects and are used as medicines or food supplements. Stigmasterol has shown anticancer effects against various cancers such as hepatoma, cholangiocarcinoma, gall bladder carcinoma, endometrial adenocarcinoma and skin, gastric, breast, prostate, and cervical cancer. However, there are no reports on stigmasterol's effects on ovarian cancer.

Methods: We investigated the effects of stigmasterol on proapoptotic signals, mitochondrial function, reactive oxygen species production, and the cytosolic and mitochondrial calcium levels in human ovarian cancer cells, to understand the mechanisms underlying the effects of stigmasterol on ovarian cancer cells. We also conducted migration assay to confirm whether that stigmasterol inhibits ovarian cancer cell migration.

Results: Stigmasterol inhibited development of human ovarian cancer cells. However, it induced cell apoptosis, ROS production, and calcium overload in ES2 and OV90 cells. In addition, stigmasterol stimulated cell death by activating the ER-mitochondrial axis. We confirmed that stigmasterol suppressed cell migration and angiogenesis genes in human ovarian cancer cells.

Conclusions: Our findings suggest that stigmasterol can be used as a new treatment for ovarian cancer.

Citing Articles

Stigmasterol Attenuates Triple-negative Breast Cancer Stem Cell Properties by Inhibiting JAK3.

Zhou R, Zhang Y, Xu L, Sun Y J Cancer. 2025; 16(5):1618-1630.

PMID: 39991585 PMC: 11843247. DOI: 10.7150/jca.94822.


Cannabidiol attenuates lipid metabolism and induces CB1 receptor-mediated ER stress associated apoptosis in ovarian cancer cells.

Fu X, Yu Z, Fang F, Zhou W, Bai Y, Jiang Z Sci Rep. 2025; 15(1):4307.

PMID: 39910152 PMC: 11799381. DOI: 10.1038/s41598-025-88917-1.


Radix Codonopsis: a review of anticancer pharmacological activities.

Liu C, Li Z, Cheng F, Nan Y, Li W Front Pharmacol. 2025; 15():1498707.

PMID: 39840099 PMC: 11747557. DOI: 10.3389/fphar.2024.1498707.


Network Pharmacology and Molecular Docking Study on the Mechanism of the Therapeutic Effect of Strychni Semen in NSCLC.

Geng H, Xue Y, Yan B, Lu Z, Yang H, Li P Biol Proced Online. 2024; 26(1):33.

PMID: 39736533 PMC: 11687011. DOI: 10.1186/s12575-024-00259-w.


Antimicrobial Properties and Therapeutic Potential of Bioactive Compounds in : A Review.

Abbas M, Gururani M, Ali A, Bajwa S, Hassan R, Wajiha Batool S Molecules. 2024; 29(20).

PMID: 39459282 PMC: 11510594. DOI: 10.3390/molecules29204914.


References
1.
Li K, Yuan D, Yan R, Meng L, Zhang Y, Zhu K . Stigmasterol exhibits potent antitumor effects in human gastric cancer cells mediated via inhibition of cell migration, cell cycle arrest, mitochondrial mediated apoptosis and inhibition of JAK/STAT signalling pathway. J BUON. 2018; 23(5):1420-1425. View

2.
Pinton P, Giorgi C, Siviero R, Zecchini E, Rizzuto R . Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis. Oncogene. 2008; 27(50):6407-18. PMC: 2844952. DOI: 10.1038/onc.2008.308. View

3.
Moloney J, Cotter T . ROS signalling in the biology of cancer. Semin Cell Dev Biol. 2017; 80:50-64. DOI: 10.1016/j.semcdb.2017.05.023. View

4.
Lian I, Loset M, Mundal S, Fenstad M, Johnson M, Eide I . Increased endoplasmic reticulum stress in decidual tissue from pregnancies complicated by fetal growth restriction with and without pre-eclampsia. Placenta. 2011; 32(11):823-9. PMC: 3210381. DOI: 10.1016/j.placenta.2011.08.005. View

5.
Osaki M, Oshimura M, Ito H . PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis. 2004; 9(6):667-76. DOI: 10.1023/B:APPT.0000045801.15585.dd. View